Global Hemp Group Announces Acquisition of Cash Crop Today Media | CashCropToday
0 Shares 1305 Views

Global Hemp Group Announces Acquisition of Cash Crop Today Media

June 1, 2018
1305 Views

This morning, Canadian public company Global Hemp Group Inc. announced that it has made a US$150,000 investment, comprised of US$60,000 in cash and the issuance of 600,000 common shares of GHG stock, in exchange for a 50% interest in Cash Crop Today Media, LLC.


Cash Crop Today Media, LLC. provides an outlet for hemp and cannabis companies to advertise and showcase their services and products through various owned and managed digital platforms.  CashCropToday.com provides timely information on a wide range of topics including material that could aid in the decision making process for investment opportunities in the hemp and cannabis industries, along with entrepreneurship, politics, and technological advancements in the industry.  The CCT Media platform fills a void in these sectors, by keeping its audience informed and involved with daily news focused on these rapidly emerging industries.

When researching and developing Cash Crop Today Media and CashCropToday.com, it became clear that both large and small scale companies were only afforded a handful of portals that promote and advertise their businesses, most of which were focused on the consumption and lifestyle of cannabis. By attracting a diverse audience that is focused on receiving investment information on both the hemp and cannabis sectors, Cash Crop Today Media can deliver an array of business to business and business to consumer marketing services such as digital media placement and advertising, curated video content development, management of social media campaigns, and regional, national, and international distribution.

CCT is a collection of businesses, entrepreneurs and investors that promote an environment of collaboration, to meet and become part of the Cash Crop Today Society. The CCT society empowers entrepreneurs and businesses to discover the necessary resources and provide an environment to meet the pioneers and strategic partners that will enable them to succeed.  The F.A.M (Farmers, Analysist, and Manufacturers) and Profiled Community Members will bridge the gap that enables companies to grow and entrepreneurs to evolve. (http://cashcroptoday.com/society/)

CCT will be hosting its first annual Investor & Business Resource Summit 2018 on June 8th and 9th at the Sofitel Hotel in Beverly Hills, California. The event will offer investors, entrepreneurs, business owners and Cash Crop Today Society Members an opportunity network with some of the pioneers of the hemp and cannabis industry and discuss their areas of expertise, experiences and unique perspectives. (http://cashcroptoday.com/ibrs)

Dave Hill, CEO of Cash Crop Today stated, “We are excited to partner with Global Hemp Group. This acquisition highlights the evolution of the industry and the progress of both companies. The assistance from their people and providing the necessary capital resources to continue to expand operations will help us create shareholder value for both companies.”

You may be interested

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon
Market Watch
269 views
Market Watch
269 views

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon

Editor - November 27, 2018

Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition
Global
191 views
Global
191 views

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition

Editor - November 26, 2018

Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
Manufacturing
189 views
Manufacturing
189 views

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials

Editor - November 26, 2018

GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: